Reveri launches major rebrand

Listen to article

Reveri, the clinically-backed self-hypnosis app, is today rolling out a major rebrand look and feel to mark its entry into the health-tech category

Co-founded by Dr. David Spiegel, a world-leading psychiatrist at Stanford University with over 45 years experience in clinical hypnosis, and Ariel Poler, a Silicon Valley investor and technology leader, reveri started in the US in 2020. With no proactive marketing efforts, reveri was able to grow its user base organically, to over 300,000 registered users.

To lead the re-brand, reveri's Chief Marketing Officer Louise Troen (ex Headspace and Bumble CEO) approached Shoreditch-based design studio Mother Design with the challenge of developing an aesthetic identity that would successfully communicate the brand proposition, break down the traditional conventions of the wellness industry, and define reveri’s entry into the self-hypnosis category in the UK.

The challenge? To build a distinctive creative brand world which reinforced reveri’s position as a challenger brand in the mental health and wellness space.

The new visual identity blends the philosophy of reveri as a brand with the functionality of the user interface as a product. The conceptual rigour stemming from the importance of ‘focus’ - both for the practice of hypnosis and for the user experience - is something that has permeated every element of the visual ID, and shaken up all elements of the user experience; from the in-app interface to reveri own channels (including website and social).

Now, with an ever growing community of ambassadors and advocates, reveri has sights set on rapid UK and global growth, to continue its mission of bringing digitised self-hypnosis to the masses. With the brand platform ‘Find Your Focus’, the rebrand is the next step in showing consumers that hypnotherapy doesn’t just have to be a last resort; its improvements on the mind-body connection can benefit you every day.

Download reveri on the App Store or Google Play for a 7-day trial, with subscriptions available from £89.99 (£10.99 a month) or visit